• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
  • IgAN Care
  • About Us
        • MM About

          • About Us
          • Leadership Team
          • Board of Directors
          • Medical & Scientific Advisory Board
        • MM About 2

          • Articles
          • Sponsors
          • Our Partners
  • Resources
        • MM – Resource 1

          • What is IgAN
          • Diagnosis
          • Understanding Your Lab Results
          • Understanding Your Biopsy
        • MM – Resource 2

          • IgAN Info
          • Faces of IgAN
          • IgAN Risk Quiz
          • American Asian Info
          • FAQ
          • IgAN Cookbook
        • MM – Resource 3

          • Support Options
          • Apply for Patient Aid
          • Patient Support
        • MM – Resource 4

          • Learning & Resources
          • Webinars
          • Guides & Fact Sheets
          • Nutrition & Recipes
          • Mental Health
          • Learn About Insurance
          • Podcasts
          • Treatment Options
  • Research
        • MM Research

          • IgA Nephropathy Studies
          • IgA Nephropathy Research
        • Clinical Trials

          • Clinical Trials
  • Join
        • MM – Join 1

          • Events
          • Calendar of Events
          • IgA Nephropathy Day
          • Rare Disease Day
        • MM – Join 2

          • Become a Member
          • Ambassador Program
          • Ways to Give
  • For Health
    Care Professionals
    Hidden for now, remove the “hide” class when available.
  • Donate
  • IgAN Care

IgA Nephropathy Foundation Announces Launch of Medical and Scientific Advisory Board


May 25, 2022

May 25, 2022 – The IgA Nephropathy Foundation (IGAN Foundation), a nonprofit dedicated to supporting patients with a rare autoimmune kidney disease called IgA Nephropathy, today announced its formation of a Medical and Scientific Advisory Board (Advisory Board). With the members’ diverse medical and scientific backgrounds, the Advisory Board will help inform and enhance the Foundation’s work in supporting IgA Nephropathy patients and their loved ones.

The Advisory Board will serve an invaluable role in guiding the IgAN Foundation’s leadership and board of directors to make decisions that are rooted in deep scientific and clinical understanding. Currently comprised of seven members, including medical professionals, researchers and experts in IgA Nephropathy, the Advisory Board will grow to no more than 20 members who will help advance the Foundation’s mission to find a cure for IgA Nephropathy, fund research, empower patients and build a strong support network for patients.

“At the Foundation, we strive to provide our community with the most up-to-date resources and support they need to navigate their condition,” said Bonnie Schneider, co-founder and director of the IGAN Foundation. “With the Advisory Board’s support, we can ensure we continue to bring medically and scientifically sound advice and resources to our members. I am so grateful to this committed team of experts for their support in driving our work forward.”

IgA Nephropathy is an autoimmune disease that attacks the kidneys. It occurs when abnormal antibody immunoglobulin A’s (IgA) are produced, causing other protective antibodies to form a complex with the IgA in the kidney and trigger an immune system attack that prevents normal kidney function. It is estimated that 20%-40% of patients with the disease will need dialysis and/or a kidney transplant to survive.

“It is very encouraging to see the marked increase in clinical research on IgA Nephropathy, which has had no treatment until the approval of the first-ever treatment for IgA Nephropathy in late 2021. Accurate understanding of this rare condition by both patients and clinicians is critical as the medical community unites to research a cure,” said Jonathan Barratt, MD, chairman of the Advisory Board and Mayer Professor of Renal Medicine at the University of Leicester. “I am proud to partner with my fellow Advisory Board members to lend our shared knowledge and expertise to the IGAN Foundation to enhance patients’ understanding of this disease and how to best manage their condition.”

The Advisory Board will provide insights and updates on the latest research and news pertaining to the treatment and care of IgA Nephropathy patients. The Advisory Board will also assist the Foundation by reviewing clinical trials, providing expert guidance and recommendations on the Foundation’s work, serving as media ambassadors and promoting the Foundation’s services among patients.

In addition to Dr. Jonathan Barratt serving as chairman, the Advisory Board currently includes: Kelly Chen, an IgA Nephropathy patient and nurse practitioner; Dr. Jared R. Hassler, a pathologist at The Temple University Hospital in Philadelphia; Dr. Li-Li Hsiao, creator of the Kidney Disease Screening and Awareness Program; Lauren Levy, MS, renal dietitian and owner of Happy Health Nutrition LLC; Dr. Daniil Shimonov, a specialist in nephrology and hypertension at The Rogosin Institute in New York, NY; and Whitney Simmons, APRN-CNP, a nurse practitioner supervisor at an ambulatory infusion center in Oklahoma City, OK.

For more information about the Medical and Scientific Advisory Board, visit https://igan.org/medical-scientific-advisory-board/

***

About the IgA Nephropathy Foundation:

As the only dedicated patient advocacy group for people affected by IgA nephropathy, the IgA Nephropathy Foundation’s mission is to be a patient-centric organization focused on finding a cure for IgA nephropathy. Using the power of the patient community, we are focused on funding research, using patient advocacy to empower our patients, and building a network of support. As a patient-run organization, we will work together with the hope of finding better treatment options and the ultimate cure. By patients, for patients. To learn more, visit igan.org.

MEDIA CONTACTS

Bonnie Schneider, bonnie@igan.org

Collin Walden, collin.walden@curastrategies.com

Category: News & Media

Return to all Articles

Donate
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Quick Links

  • About Us
  • Patient Resources
  • Research
  • Contact Us
  • Join Our Efforts

Contact Us

(848) 298-4618

(732) 681-3462

PO Box 1322 Wall, NJ 07727

© 2023 All Rights Reserved.

May 14, Sunday: Mother’s Day & IgA Nephropathy Awareness Day

The IgAN Foundation was sparked by a mother’s love and has grown into a community sharing crucial resources and working toward a cure. This day kicks off a week of celebrating the IGA Nephropathy family all week!

May 15, Monday: Mindfulness

IgA Nephropathy can be challenging and mindfulness is an important part of caring for yourself. Take a moment today and implement a mindfulness practice, meditate, or take a few moments in reflection to check in with yourself.

May 16, Tuesday: Share Your Story

On this day, the Foundation will share the video with Warrior stories compiled (submit yours here if you haven’t yet). We encourage you to also share your own photos and videos from moments along your journey!

May 17, Wednesday: Wellness

What are you doing to feel well today? IgA Nephropathy can sometimes make life feel uncontrollable, but there are some things we can control, for example:

  • Enjoyable movement (a stretch, a walk, dancing to a favorite song)
  • Eating food that’s right for us individually
  • Checking in with ourselves
  • Meditating

May 18, Thursday: Thank those who care

Between care teams, care partners, and medical providers, a lot goes into the care that sustains us as we live with IgA Nephropathy. Take this opportunity to express your appreciation to them!

May 19, Saturday: Rally cry

When the IgA Nephropathy Foundation was created, there were no resources to treat IgA Nephropathy. Now, there are 2 approved FDA treatments and many clinical trials in the works. Our community is strong and full of hope— here’s to even more progress in the future!

May 20, Saturday: Celebration! 

We’ll be hosting an in-person celebration (details to come). We’ll miss you if you can’t make it, but please take the time to celebrate however works for you — wearing your IgAN Foundation sunglasses, spending time with loved ones, etc. — just be sure to share a photo and tag us!

References

  • Hall, Y.N., Fuentes, E.F., Chertow, G.M. et al. Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol 5, 10 (2004). https://doi.org/10.1186/1471-2369-5-10
  • Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, et al. (2012) Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis. PLoS Genet 8(6): e1002765. doi:10.1371/journal.pgen.1002765